- Caidya is a leading global mid-sized clinical research organization (CRO) specializing in clinical development, operations, and regulatory services, with a focus on innovative solutions for clinical trials.
- In January 2025, Caidya secured a $165 million strategic growth investment from Rubicon Founders, and in November 2025, they enhanced their service offerings by integrating Medidata AI-powered solutions into their clinical trial management processes.
- Caidya has established partnerships with Medidata and has a strong customer base that includes pharmaceutical and biotech companies seeking advanced clinical trial solutions.
- Caidya's ideal buyers are pharmaceutical and biotech companies looking to streamline clinical trial processes and improve patient engagement, making them a key player for sales teams targeting the life sciences sector.
Healthcare roles represent the largest share at 115 employees (about 33%). Engineering (46; ~13%) and Business Management (43; ~12%) form sizable portions of the team, followed by Program and Project Management (32; ~9%) and Finance and Administration (31; ~9%). Additional functions include Information Technology (20; ~6%), Sales and Support (17; ~5%), Human Resources (12; ~3%), and Marketing and Product (11; ~3%), with 23 employees categorized as Other (~7%). This mix highlights a balance between clinical, technical, and business capabilities within the organization.
The workforce is widely distributed, with 267 employees classified as Other (about 76% of total headcount). Named locations include Raleigh, NC (29), Cary, NC (9), Durham, NC (9), and Philadelphia, PA (9), as well as Boston, MA (7), Thiruvananthapuram, India (6), Charlotte, NC (5), United Kingdom (5), and Nashville, TN (4). Collectively, the named locations account for roughly a quarter of the employee base, indicating a broad geographic footprint alongside a large unspecified or distributed segment.
